--- title: "Hong Kong stock movement: BUTONG GROUP's stock price rises 15.37%, what market signals are hidden behind the lack of important news?" type: "News" locale: "en" url: "https://longbridge.com/en/news/283779591.md" description: "BUTONG GROUP rose by 15.37%; Giant Biologics rose by 0.69%, with a transaction volume reaching HKD 115 million; Shangmei Co., Ltd. rose by 2.50%, with a transaction volume reaching HKD 74 million; Hengan International rose by 0.15%, with a transaction volume reaching HKD 58.89 million; Mao Geping fell by 1.38%, with a market value of HKD 36.9 billion" datetime: "2026-04-23T06:56:49.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/283779591.md) - [en](https://longbridge.com/en/news/283779591.md) - [zh-HK](https://longbridge.com/zh-HK/news/283779591.md) --- # Hong Kong stock movement: BUTONG GROUP's stock price rises 15.37%, what market signals are hidden behind the lack of important news? **Hong Kong Stock Movement** BUTONG GROUP rose by 15.37%, with no significant news recently. Trading is active, and capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. **Stocks with High Trading Volume in the Industry** Juzhi Biotechnology rose by 0.69%. Based on recent key news: 1. On April 20, Juzhi Biotechnology announced the cancellation of 9.2 million repurchased shares. This move reduced the company's issued shares to 1,061,704,000 shares, and the market's positive response to the company's equity structure adjustment drove the stock price up. Source: Zhitong Finance 2. On April 20, Juzhi Biotechnology submitted a disclosure to the Hong Kong Stock Exchange the next day, detailing the share repurchase and cancellation situation. The repurchase price averaged between HKD 33.6 and 36.07 per share, and the market's recognition of the company's repurchase plan further supported the stock price. Source: Zhitong Finance 3. No other significant news recently. The Hong Kong stock market has been volatile lately, and investors should be cautious. Shangmei Co., Ltd. rose by 2.50%. Based on recent news, 1. On April 22, the "Girl's Needle" received approval for 4 licenses, with supply relatively scarce. Manufacturers are expected to break through through brand operation, doctor education, and medical promotion, driving the stock price up. 2. On April 20, data from the National Bureau of Statistics showed that in March, China's cosmetics retail sales grew by 8.3%, with a cumulative growth rate of 5.9% in Q1, confirming the resilience of beauty demand and driving Shangmei Co., Ltd.'s stock price up. 3. On April 20, Shenwan Hongyuan released a research report stating that it is expected that Q2 26, especially during the 618 promotion, will see new highs in growth rates, with stable revenue and profit growth on the brand side and marginal improvements on the manufacturing side, supporting Shangmei Co., Ltd.'s stock price increase. The recovery of beauty demand indicates an optimistic industry outlook. Hengan International rose by 0.15%, with a trading volume of HKD 58.89 million, and no significant news recently. Trading is active, and capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. **Stocks with High Market Capitalization in the Industry** Mao Ge Ping fell by 1.38%. Based on recent news, 1. On April 20, Shenwan Hongyuan released a research report indicating that in March, China's cosmetics retail sales grew by 8.3%, with a cumulative growth rate of 5.9% in Q1, showing the resilience of beauty demand and a trend of monthly recovery. Mao Ge Ping, as one of the core recommended targets, benefits from stable revenue and profit growth on the brand side and marginal improvements on the manufacturing side. 2. On April 22, market analysis pointed out that although the beauty industry demand is yet to recover, Mao Ge Ping, with its high-end positioning and cost-effectiveness, is expected to stand out in the competition. The recovery of beauty demand indicates fierce competition ### Related Stocks - [06090.HK](https://longbridge.com/en/quote/06090.HK.md) ## Related News & Research - [00:29 ETBioQ debuta en in-cosmetics Global, demostrando la creciente fortaleza de China en innovación de ingredientes](https://longbridge.com/en/news/286357072.md) - [China’s Booming Cosmetics Market Opens Opportunities for French Beauty Firms, Industry Body Exec Says](https://longbridge.com/en/news/286544802.md) - [Premium skincare brand Forest Cabin will study L’Oreal, but not copy it: CEO interview](https://longbridge.com/en/news/286831488.md) - [08:57 ETCrunchCup Secures U.S. Utility Patent](https://longbridge.com/en/news/286917029.md) - [AI|China’s Ganfeng secures orders amid surge in demand for energy storage, AI boom](https://longbridge.com/en/news/286895092.md)